0.45% SODIUM CHLORIDE INJECTION USP SOLUTION

Land: Canada

Sprog: engelsk

Kilde: Health Canada

Aktiv bestanddel:

SODIUM CHLORIDE

Tilgængelig fra:

B. BRAUN MEDICAL INC

ATC-kode:

B05XA03

INN (International Name):

SODIUM CHLORIDE

Dosering:

4.5MG

Lægemiddelform:

SOLUTION

Sammensætning:

SODIUM CHLORIDE 4.5MG

Indgivelsesvej:

INTRAVENOUS

Enheder i pakken:

500ML/1000ML

Recept type:

Ethical

Terapeutisk område:

REPLACEMENT PREPARATIONS

Produkt oversigt:

Active ingredient group (AIG) number: 0100053005; AHFS:

Autorisation status:

APPROVED

Autorisation dato:

1998-04-29

Produktets egenskaber

_0.45% Sodium Chloride Injection USP Prescribing Information _
_Page 1 of 10_
PRESCRIBING INFORMATION
0.45 % SODIUM CHLORIDE INJECTION USP
Solution, Intravenous
IV Fluid and Electrolyte Replenisher
B. BRAUN MEDICAL INC. Date of Preparation:
824 Twelfth Avenue
August 24, 2020
Bethlehem, PA 18018-3524 USA
Distributed by:
B. BRAUN OF CANADA, LTD.
2000 Ellesmere Road, Unit 16
Scarborough, Ontario M1H 2W4
Submission Control No: 235120
_ _
_0.45% Sodium Chloride Injection USP Prescribing Information _
_Page 2 of 10_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.................................................... 3
1
INDICATIONS
......................................................................................................
3
1.1
PEDIATRICS
...................................................................................................
3
1.2
GERIATRICS
....................................................................................................
3
2
CONTRAINDICATIONS
.......................................................................................
3
3
DOSAGE AND ADMINISTRATION
.....................................................................
3
3.1
DOSING CONSIDERATIONS
.............................................................................
3
3.2
RECOMMENDED DOSE AND DOSAGE ADJUSTMENT
....................................... 4
3.3
ADMINISTRATION
...........................................................................................
4
4
OVERDOSAGE
....................................................................................................
5
5
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ............. 5
6
WARNINGS AND PRECAUTIONS
......................................................................
6
6.1
SPECIAL
POPULATIONS...................................................................................
7
6.1.1
PREGNANT WOMEN
.................................................................................
7
6.1.2
BREAST-FEEDING
...............................